Cyclosporine dose fractioning might affect renal function in stable heart transplanted patients

Transplantation Proceedings

Volumn 33, Issue 7-8, 2001, Pages 3151-3153

  Baraldo, M ^a   Pea, F ^a   Poz, D ^a   Albanese, M C ^b   Livi, U ^b   Furlanut, M ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b SANTA MARIA DELLA MISERICORDIA UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A; DILTIAZEM;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG BLOOD LEVEL; FOLLOW UP; HEART TRANSPLANTATION; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; PATIENT; PRIORITY JOURNAL;

CALCINEURIN; CYCLOSPORINE; DRUG ADMINISTRATION SCHEDULE; FOLLOW-UP STUDIES; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY FUNCTION TESTS; REGRESSION ANALYSIS; TIME FACTORS;

EID: 0035678695     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(01)02342-9     Document Type: Article

References (11)

1. Kahan BD: N Engl J Med 321:1725, 1989
2. Heartmann A, Andersen AK, Holdeas H, et al: J Heart Lung Transplant 15:972, 1996
3. Myres BD: Kidney Int 30:964, 1986
4. Halloran PF, Helms LM, Kung L, et al: Transplantation 68:1356, 1999
5. Furlanut M, Baraldo M, Albanasese, et al: Transplant Proc 26:2574, 1994
6. Furlanut M, Baraldo M, Pea F, et al: Ther Drug Monit 18:544, 1996
7. Olyaei AJ, deMattos AM, Bennett WM: Drug Saf 16:366, 1997
8. Cockroft DW, Gault MH: Nephron 16:31, 1976
9. Belitsky P, Levy GA, Johnston A: Transplant Proc 32 (suppl 3A):45S, 2000
10. Dieperink H, Leyssac PP, Starklint H, et al: Transplant Proc 20:703, 1988
11. Kahan BD: Transplant Proc 26:3082, 1994